Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Hypertension. 2021 Nov 1;78(6):1750–1759. doi: 10.1161/HYPERTENSIONAHA.121.17875

FIGURE 3:

FIGURE 3:

Serum biomarkers of inflammation, as assessed by C-reactive protein (panel A), Tumor Nercrosis Factor-α (panel B), and Interleukin-6 (panel C) in controls and patients with HFpEF. * Significantly different than control, P < 0.05. HFpEF n = 27; Control n = 35. Data are mean ± SEM